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Purpose: To compare the cytological results of ultrasound-guided fine-needle as-
piration (US-FNA) cytology of thyroid nodules to sonographic findings and deter-
mine whether US findings are helpful in the interpretation of cytological results. 
Materials and Methods: Among the thyroid nodules that underwent US-FNA cy-
tology, we included the 819 nodules which had a conclusive diagnosis. Final diag-
nosis was based on pathology from surgery, repeated FNA cytology or follow-up 
of more than one year. Cytological results were divided into five groups: benign, 
indeterminate (follicular or Hurthle cell neoplasm), suspicious for malignancy, ma-
lignant, and inadequate. US findings were categorized as benign or suspicious. Cy-
tological results and US categories were analyzed. Results: Final diagnosis was 
concluded upon in 819 nodules based on pathology (n=311), repeated FNA cytol-
ogy (n=204) and follow-up (n=304), of which 634 were benign and 185 were ma-
lignant. There were 560 benign nodules, 141 malignant nodules, 49 nodules with 
inadequate results, 21 with indeterminate results, and 48 that were suspicious for 
malignancy. The positive and negative predictive values of the US categories were 
59.1% and 97.0%, and those of the cytological results were 93.7% and 98.9%. The 
US categories were significantly correlated with final diagnosis in the benign 
(p=0.014) and suspicious for malignancy (p<0.001) cytological result groups, but 
not in the inadequate and indeterminate cytological results groups. The false posi-
tive and negative rates of cytological results were 1.9% and 3.2%. Conclusion: So-
nographic findings can be useful when used alongside cytological results, especially 
in nodules with cytological results that are benign or suspicious for malignancy.
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INTRODUCTION
Fine-needle aspiration (FNA) cytology is a widely accepted diagnostic modality 
for thyroid nodule evaluation1-7 and several reports have suggested that ultrasound 
(US)-guided FNA cytology has many advantages over palpation-guided biopsy.5,8 
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tained. Echogenicity was classified as hyperechogenicity, 
isoechogenicity, hypoechogenicity, and marked hypoecho-
genicity. When the echogenicity was similar to thyroid pa-
renchyma, the nodule was classified as isoechogenic. 
Marked hypoechogenicity indicated lower echogenicity 
than the surrounding strap muscle. The margin was charac-
terized as well- or not well-circumscribed (microlobulated/
irregular). Calcifications were categorized as microcalcifica-
tions, macrocalcifications, mixed calcifications, or none. Mi-
crocalcifications were defined as tiny (less than 2 mm in 
size), punctuate, and hyperechoic foci, either with or without 
acoustic shadows. Macrocalcifications were defined as larg-
er than 2 mm. Mixed calcifications were defined as a combi-
nation of micro- and macrocalcifications. Shape was as-
sessed by the ratio of anteroposterior (A) and transverse (T) 
diameter (A/T ≥1 or A/T <1). Mixed nodules, composed of 
both cystic and solid portions, were classified according to 
the solid portion. Malignant sonographic features were de-
fined as showing marked hypoechogenicity, not well-cir-
cumscribed margin, microcalcifications or mixed calcifica-
tions, and A/T ≥1. If any single feature suggestive of 
malignancy was present, the nodule was classified as suspi-
cious. If a nodule had no suspicious features, it was classi-
fied as benign. 
FNA cytology procedure
Informed consent for the procedure was obtained from all 
patients. FNA cytology was performed by an experienced 
radiologist using US guidance. FNA cytology was not done 
for purely cystic lesions. Immediate specimen adequacy 
evaluation by a cytopathologist was not conducted. During 
US-FNA cytology, patients were placed supine with the neck 
slightly extended. After lesion localization, the neck was pre-
pared in a sterile environment and draped. Local anesthetic 
was not used. A 23-gauge needle attached to a 20-mL sy-
ringe with holder was placed just above the transducer. Un-
der observation, the needle tip was inserted perpendicularly 
to the neck, seen visibly as a bright spot on the monitor. 
With mixed nodules, the needle was introduced toward the 
solid portion. The biopsy was performed with to-and-fro 
movements; suction was released before the needle was re-
moved. During the procedure, all needle movements were 
continuously monitored in real time. A minimum of 2 pass-
es were employed. Aspirated material was placed, smeared, 
and fixed on glass slides and stained with Papanicolaou and 
Giemsa stain. Flushed material was placed in sterile normal 
saline for cell block. 
Real-time US permits needle visualization within the le-
sion, thereby facilitating an accurate biopsy on small non-
palpable nodules. Even with palpable nodules, US-FNA 
cytology is superior in obtaining adequate tissue for accu-
rate cytological evaluation.5,9,10 
However, there are limitations to US-FNA cytology, in-
cluding results that are categorized as inadequate, indeter-
minate, or suspicious aspirates. Additionally, false-negative 
cytological results were reported to be as low as 0-6.2%.10-12 
To date, there have only been a few studies investigating 
the correlation between cytological results and sonographic 
classification. The purpose of this study was to compare the 
cytological results of thyroid nodules to sonographic find-
ings in nodules that have been clinically proven benign by 
repeated FNA cytology or follow-up, and to determine 
whether US findings are helpful in the interpretation of cy-
tological results. 
MATERIALS AND METHODS
　　　
Patients
This retrospective study was approved by the institutional 
review board. Informed consent was not required. From 
September 2002 to July 2003, 1048 thyroid nodules in 999 
consecutive patients underwent US and US-FNA cytology 
performed by one radiologist. There were 928 women and 
71 men between the ages of 12 and 82 years (mean age: 48 
years). Final diagnoses were based not only on pathology 
from surgery but also repeated FNA cytology or follow-up 
of more than one year. When there was no change after 
more than one year of follow-up or the nodule showed the 
same cytological results after repeated FNA cytology, we 
designated the nodule as benign. Indeterminate, suspicious 
for malignancy, or inadequate cytological results were ex-
cluded if patients had not undergone an operation.
Sonographic evaluation
Thyroid US was performed by an HDI 3000 or 5000 scan-
ner (Phillips, Bothell, WA, USA) with a 7- to 12-MHz band-
width transducer. Compound imaging was performed with 
the HDI 5000 in all cases. Sonographic classification based 
on sonographic features was performed before FNA cytolo-
gy by one experienced radiologist. Size was measured as the 
longest diameter. Sonographic features included echogenici-
ty, margin, calcifications, and shape, based on our previous 
publication.13 Color Doppler imaging was not routinely ob-
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when the cytologically proven benign nodules showed no 
change on follow-up US after more than a year, they were 
also included in the ultimately benign group.
Statistical analysis
Sonographic findings were analyzed according to cytologi-
cal results in cases with final diagnoses. The positive pre-
dictive value (PPV), negative predictive value (NPV) and 
accuracy of US categories and cytological results were cal-
culated. Only benign, suspicious for malignancy and malig-
nant cytological results were included in these analyses; in-
adequate and indeterminate cases were excluded. The mean 
sizes of benign and malignant nodules were compared us-
ing a t-test. In each cytological results group, US categories 
and final diagnoses were compared using Fisher’s exact test. 
Statistically significant differences were defined as those 
with p-values of less than 0.05, and analyses were per-
formed using the Statistical Package for the Social Sciences 
(SPSS, version 18; SPSS, Chicago, IL, USA).
RESULTS
 
Fig. 1. shows the schematic flow of this study and final di-
agnosis. Among the 1,048 thyroid nodules underwent FNA 
cytology, final diagnoses were concluded in 819 nodules 
based on pathology from surgery (n=311), repeated FNA 
cytology (n=204) or follow-up of over a year (n=304). There 
were 634 (77.4%) benign (35 male and 599 female; age 12-
79 years old) and 185 (22.6%) malignant (14 male and 171 
Cytological and pathological evaluation
Cytology was interpreted by five cytopathologists and the 
results were reported as adequate or inadequate. A speci-
men was considered adequate if there were a minimum of 
six groupings of well-preserved thyroid cells, consisting of at 
least 10 cells per group.14 Specimens were diagnosed as be-
nign, indeterminate (follicular or Hurthle cell neoplasm), 
suspicious for malignancy, or malignant. Benign cytology 
included colloid nodules, adenomatous hyperplasia, lym-
phocytic thyroiditis, Graves’ disease, and postpartum thy-
roiditis. The interpretation of “suspicious for malignancy” 
on cytology was defined when the specimen manifested 
varying cytological abnormalities associated with papillary 
carcinoma such as nuclear membrane irregularity, nucleolar 
abnormality, abnormal nucleus-to-cytoplasm ratio, but did 
not fulfill the criteria for a diagnosis of papillary carcinoma.
Pathological results were recorded as benign or malignant in 
the medical records. Malignant results included papillary, fol-
licular, medullary and undifferentiated thyroid carcinoma. 
Follow-up after FNA cytology
On principle, we recommended operation in cases where the 
cytological results are malignant, suspicious for malignancy, 
or indeterminate. We also recommended follow-up FNA cy-
tology for cases with inadequate cytology and follow-up US 
for those with benign cytology. Therefore, we retrospectively 
reviewed the medical records of follow-up FNA cytology or 
US results in patients who did not undergo operation. When 
the cytological results from repeated FNA cytology were be-
nign, these nodules were included in the final diagnosis, and 
Fig. 1. Final diagnosis of the study population. FNA, fine-needle aspiration; Op, operation; NIC, no interval change. *from operation, **from 
repeated FNA cytology or NIC.
Thyroid nodules underwent FNA cytology (n=1,048)
Final diagnosis (n=819)
Benign 634 Malignant 185
Inadequate (n=109)
Benign 11*+37**  
Malignant 1*
Non-Op 
(n=97)
Op 
(n=12)
Non-Op 
(n=588)
Op 
(n=89)
Non-Op 
(n=19)
Op 
(n=21)
Non-Op 
(n=17)
Op 
(n=48)
Non-Op 
(n=16)
Op 
(n=141)
Benign (n=677)
Benign 83*+471**  
Malignant 6*
Indeterminate (n=40)
Benign 20* 
Malignant 1*
Suspicious (n=65)
Benign 11* 
Malignant 37*
Malignant (n=157)
Benign 1* 
Malignant 140*
Cytology
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there were fewer malignant nodules (2/452, 0.4%) in the 
benign US category, while there were more malignant nod-
ules (4/108, 3.7%) in the suspicious US category (p=0.014) 
(Fig. 2). The US categories were also correlated with final 
diagnosis in the suspicious for malignancy cytological re-
sults group (p<0.001). Among 48 nodules with suspicious 
cytological results, 91.7% (33) of the 36 nodules in the sus-
picious US category turned out to be malignant, and 33.3% 
(4) of the 12 in the benign US category were found to be ma-
lignant (Fig. 3). However, US categories were not definitely 
correlated with final diagnosis in the inadequate, indetermi-
nate and malignant cytological result groups (Table 1). In the 
benign cytological result group, two nodules (2/560, 0.4%) 
turned out to be malignant even though the US findings 
were also benign. The false negative rate of the cytological 
result was 3.2% (6/185). Among those with suspicious for 
malignancy or malignant cytological results, four nodules 
female; age 19-77 years old) thyroid nodules. The malignant 
results were: papillary thyroid carcinoma in 183 cases (in-
cluding two follicular variants), medullary carcinoma in 
one, and minimally invasive follicular carcinoma in one. 
The mean size was larger in benign nodules [18.3 mm, (3-
100)] than in malignant nodules [11.8 mm (3-52)] (p<0.001). 
The analysis of US categories and the final diagnoses ac-
cording to the cytological results are summarized in Table 1.
The PPV, NPV and accuracy of the US categories using 
cytological results as the gold standard were 60.9%, 95.6% 
and 82.8%. When using the final diagnosis as the gold stan-
dard, the PPV, NPV and accuracy of the US categories were 
59.1%, 97.0% and 83.8%, and those of the cytological re-
sults were 93.7%, 98.9% and 97.6%. When only histologi-
cal results were considered as the gold standard, the accura-
cy of cytological results dropped to 34.7%.
Among the 560 nodules with benign cytological results, 
Table 1. US Categories and Final Diagnoses According to Cytological Results
Cytological results US categories
Mean size 
(range, mm)
Final diagnosis
Benign (%) Malignant (%) p value*
Inadequate (n=49) Benign (n=40) 20.1 (5-43)   40 (83.3)     0 0.184
Suspicious (n=9)   9.2 (4-15)     8 (16.7)     1
Benign (n=560) Benign (n=452) 19.1 (3-100) 450 (81.2)     2 (33.3) 0.014
Suspicious (n=108) 13.5 (3-60) 104 (18.8)     4 (66.7)
Indeterminate (n=21) Benign (n=20) 26.1 (12-70)   19 (95)     1 1.000
Suspicious (n=1)      6     1 (5)     0
Suspicious 
  for malignancy (n=48)
Benign (n=12) 14.9 (5-40)     8 (72.7)     4 (10.8) <0.001
Suspicious (n=36)   9.3 (3-34)     3 (27.3)   33 (89.2)
Malignant (n=141) Benign (n=9) 18.4 (4-33)     0     9 (6.4) 1.000
Suspicious (n=132) 11.9 (3-52)     1 131 (93.6)
*from Fisher’s exact test.
Fig. 2. A 50-year-old female with papillary thyroid carcinoma. (A) Ultrasonography shows well-circumscribed and isoechoic nodule (ar-
row) with a shape that is taller than it is wide and internal microcalcification in the thyroid gland; this nodule was considered suspicious. 
(B) Fine-needle aspiration cytology was interpreted as adenomatous hyperplasia based on the presence of flat sheets of follicular cells in 
the bloody background (Giemsa stain ×200 original magnification). Because of the discordant results between the sonographic findings 
and the cytological results, surgical excision was performed. (C) Thyroidectomy specimen shows a typical papillary carcinoma nucleus 
with a few grooves, clearing and pseudoinclusions, compatible with papillary thyroid carcinoma (hematoxylin and eosin (H&E) ×400 origi-
nal magnification).
A B C
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able. The rate is reported to be 6.4-23% in US-FNA cytolo-
gy,8,10 and it was 10.4% (109/1,048) in our study. Only 1 out 
of 49 (2%) was malignant on pathology, and it showed sus-
picious sonographic findings (Table 1). However, the corre-
lation between sonographic findings and pathologic results 
could not be evaluated because of the small number of ma-
lignant results (n=1). A prospective study with more patients 
is needed to resolve this issue. 
In considering indeterminate cytology, there have been 
several attempts to make definite clinical or imaging pa-
rameters for identifying patients at higher risk of malignan-
cy among follicular neoplasms on cytology, but none of 
these parameters have proved satisfactory.30-32 As in our 
study, sonographic findings are not helpful in these cases. 
There was only one malignancy (invasive follicular carci-
noma) out of 21 indeterminate cytological results in our 
study, and it was interpreted as benign on the preoperative 
US evaluation. However, the correlation between sono-
graphic findings and pathologic results also cannot be eval-
uated in this group because of the small number of malig-
nant results.
To reduce the occurrence of false-negative results, imag-
ing analysis is also important in benign cytological results. 
Our study showed that, even in benign cytology results, there 
was more malignancy in the suspicious US group than in 
the benign US group (3.7% vs. 0.4%; p=0.014). Therefore, 
even if the cytological results are benign, US findings should 
be considered for patient management. Repeated FNA cy-
tology is recommended in cases with suspicious sonographic 
findings, even when benign cytological results are obtained. 
Our study has several limitations. First, we excluded cas-
es that were not pathologically proven and that had indeter-
minate (n=19) and suspicious (n=17) cytological results. 
(4/189, 2.1%) were ultimately benign even though the US 
findings were also suspicious. The false positive rate of the 
cytological results was 1.9% (12/634).
DISCUSSION
   
FNA cytology is the most accurate and cost-effective meth-
od of evaluating thyroid nodules, although ongoing re-
search is being done on variable methods including genetic 
studies.15-17 In recent studies, the sensitivity, specificity and 
accuracy of FNA cytology have been reported as 76-98%, 
71-100%, and 69-97%, respectively.8,10-12,18-25 However, thy-
roid FNA cytology has some limitations in cases of suspi-
cious, inadequate, and indeterminate cytology. In addition, 
there are false-positive and false-negative results. There-
fore, another method is needed to compensate for these lim-
its, and we hypothesized that US could provide useful addi-
tional information.
In considering the cytological results that are suspicious 
for malignancy, the sonographic findings were significantly 
correlated with final diagnosis in our study (p<0.001), which 
has also been revealed in previous reports.26,27 Therefore, US 
features of nodules with suspicious cytological results are 
useful in planning the extent of surgery. If US findings sug-
gest benign results, an intra-operative frozen section is need-
ed and if suspicious, positive operation should be consid-
ered with informed consent for surgery.28 
Inadequate cytological results are also problematic. In 
2007, the British Thyroid Association and Royal College of 
Physicians suggested that FNA cytology should be repeated 
in cases of inadequate cytology.29 With US guidance, the 
rate of inadequacy has been decreased, but it is still unavoid-
Fig. 3. A 61-year-old female with papillary thyroid carcinoma. (A) Ultrasonography shows an irregular and marked hypoechoic nodule 
with a shape that is taller than it is wide and internal mixed calcification in the right thyroid gland; this nodule was considered suspicious. 
(B) This fine-needle aspiration cytology was interpreted as suspicious for papillary thyroid carcinoma based on the presence of a rare 
cluster of follicular cells cytological overlapping and nuclear clearing and grooves (Papanicolaou stain ×200 original magnification). (C) 
This thyroidectomy specimen shows a few papillae with typical nuclear features of papillary carcinoma, such as nuclear pseudoinclu-
sion, clearing and grooves, compatible with papillary carcinoma (H&E, ×400 original magnification). 
A B C
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5. Cesur M, Corapcioglu D, Bulut S, Gursoy A, Yilmaz AE, Erdogan 
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tion biopsy. Thyroid 2004;14:43-7.
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diagnosis and management of thyroid nodules. Cytopathology 
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ME, et al. American Association of Clinical Endocrinologists and 
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cal practice for the diagnosis and management of thyroid nodules. 
Endocr Pract 2006;12:63-102.
15. Lee KY, Huang SM, Li S, Kim JM. Identification of differentially 
expressed genes in papillary thyroid cancers. Yonsei Med J 2009; 
50:60-7.
16. Akdi A, Perez G, Pastor S, Castell J, Biarnes J, Marcos R, et al. 
Common variants of the thyroglobulin gene are associated with 
differentiated thyroid cancer risk. Thyroid 2011;21:519-25.
17. Murugan AK, Xing M. Anaplastic Thyroid Cancers Harbor Novel 
Oncogenic Mutations of the ALK Gene. Cancer Res 2011;71: 
4403-11.
18. Serna de la Saravia C, Cuellar F, Saravio Day E, Harach HR. Ac-
curacy of aspiration cytology in thyroid cancer: a study in 1 insti-
tution. Acta Cytol 2006;50:384-7.
19. Sahin M, Sengul A, Berki Z, Tutuncu NB, Guvener ND. Ultra-
sound-guided fine-needle aspiration biopsy and ultrasonographic 
features of infracentimetric nodules in patients with nodular goi-
ter: correlation with pathological findings. Endocr Pathol 2006;17: 
67-74.
20. Zagorianakou P, Malamou-Mitsi V, Zagorianakou N, Stefanou D, 
Tsatsoulis A, Agnantis NJ. The role of fine-needle aspiration biop-
sy in the management of patients with thyroid nodules. In Vivo 
2005;19:605-9.
These made up a relatively large portion of each cytological 
result category [47.5% (19/40) of the indeterminate group 
and 27.4% (17/65) of the suspicious group]. This may have 
caused a selection bias. The second limitation is that we in-
cluded nodules that were not pathologically proven and that 
had inadequate (n=37) and benign (n=471) cytological re-
sults. In clinical situations, a large number of thyroid nod-
ules are benign and almost none of these nodules undergo 
operation. When a thyroid nodule is diagnosed as benign, it 
requires follow-up or repeated FNA cytology because of a 
low (but not negligible) false-negative rate of up to 5% with 
FNA cytology.33,34 Our study also showed a 3.2% false-nega-
tive rate. Therefore, we may have included malignant nod-
ules that were considered to be benign in our study as a false-
negative case. The repeated benign cytological results 
(n=167) can be accepted as benign with a less than 1% false 
negative rate. However, benign cytological results (n=37) 
on repeated FNA cytology from inadequate cytological re-
sults may be controversial. Also, the follow-up duration 
was not long enough to exclude differentiated thyroid carci-
noma. In clinical practice, all cases with benign cytological 
results on repeated FNA cytology or no interval change on 
follow-up US are not operated upon; a study including these 
data may be more realistic. However, additional study is 
needed regarding the results of repeated FNA cytology and 
follow-up US results in the long-term.
In conclusion, sonographic findings can be useful when 
used alongside cytology in the overall assessment of thy-
roid nodules and their likelihood of malignancy. If the nod-
ule that is suspicious for malignancy on cytology also has 
suspicious findings on US, it is highly likely that it is malig-
nant. In addition, if a cytologically benign nodule shows 
suspicious sonographic findings, repeated FNA cytology is 
recommended. 
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